November 11, 2024 · Form 4 insider transaction
Draghia-Akli Ruxandra bought 64,150 shares of Novavax, Inc. at $9.01 per share, a transaction worth $578.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.